CH4 Natural Solutions Corp-A 2026年季度报告

For the quarterly period ended March 31, 2026 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF1934 For the transition period fromto Commission File Number: 001-43264 CH4 Natural Solutions Corporation(Exact name of registrant as specified in its charter) 98-1821196(I.R.S. EmployerIdentification No.) Cayman Islands(State or other jurisdiction ofincorporation or organization) 712 Fifth Avenue, 36thFloorNew York, NY(Address of principal executive offices) 10019(Zip Code) (212) 993-0076(Registrant’s telephone number, including area code) Not Applicable(Former name or former address, if changed since last report) Securities registered pursuant to Section12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to suchfiling requirements for the past 90 days.Yes☐No☒ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company,or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Largeacceleratedfiler☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☒No☐ As of June12, 2026, there were 22,200,000 ClassA ordinary shares, par value $0.0001 per share, and 7,666,667 ClassB ordinary shares, parvalue $0.0001 per share, issued and outstanding. Table of Contents CH4 NATURAL SOLUTIONS CORPORATIONQuarterly Report on Form 10-Q Table of Contents PART 1 - FINANCIAL INFORMATIONItem1.CONDENSED FINANCIAL STATEMENTSCondensed Balance Sheets as of March31, 2026 (unaudited) and December31, 20251Unaudited Condensed Statements of Operations for the three month periods ended March31, 2026 and March31, 20252Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the three month periods ended March31, 2026 andMarch31, 20253Unaudited Condensed Statements of Cash Flows for the three month periods ended March31, 2026 and March31, 20254Notes to Unaudited Condensed Financial Statements5Item2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS16Item3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK20Item4.CONTROLS AND PROCEDURES20PART II - OTHER INFORMATIONItem1.LEGAL PROCEEDINGS20Item1A.RISK FACTORS20Item2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS20Item3.DEFAULTS UPON SENIOR SECURITIES20Item4.MINE SAFETY DISCLOSURES21Item5.OTHER INFORMATION21Item6.EXHIBITS22SIGNATURES24 Table of Contents PART I - FINANCIAL INFORMATION CH4 NATURAL SOLUTIONS CORPORATIONCONDENSED BALANCE SHEETS MARCH31,2026(unaudited)DECEMBER31,2025ASSETSCurrent asset—prepaid expenses$31,827$31,827Deferred offering costs1,073,6061,018,517Total assets$1,105,433$1,050,344LIABILITIES AND SHAREHOLDERS’ DEFICIT Commitments and Contingencies (Note 6)Shareholders’ Deficit Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding (1)This number includes an aggregate of 1,000,000 ClassB ordinary shares that were subject to forfeiture if the over-allotment option was notexercised in full by the underwriter. On May6, 2026, the underwriter partially exercised the over-allotment option and on May8, 2026, purchased2,000,000 units under the over-allotment option, reducing the shares subject to forfeiture to 333,333. The underwriter has until 45 days from thedate of the Company’s Prospectus dated April30, 2026 (the “Prospectus”) to exercise the remaining 1,000,000 units under the over-allotmentoption. (see Note 4).(2)In November 2025, the Company effected a share dividend with respect to the Company’s founder shares of 4,312,500 shares thereof, resulting in the Sponsor owning an aggregate of 11,500,000 founder shares. On April22, 2026, our sponsor surrendered to us for no consideration anaggregate of 3,833,333 founder shares, which we accepted and canceled, resulting in our sponsor owning 7,666,667 founder shares forapproximately $0.003 per share, due to the changes in the offering size. All share and per